Partner Headlines - TEVA

  1. Teva Unveils Generic Lunesta Tablets in US

    Benzinga
  2. Teva Announces First Approval and Launch of Generic Lovaza® Capsules ...

    Benzinga
  3. Market Wrap For April 7: Bears In Complete Control As Markets ...

    Benzinga
  4. Citigroup Slaps $70 Price Target on Teva, Highest on Street

    Benzinga
  5. Market Wrap For March 31: Stocks Rally As Yellen Confirms Support ...

    Benzinga
  6. Analyst Offers Insight on Favorable FDA Ruling for Teva Pharma

    Benzinga
  7. Market Wrap For March 28: Markets Still Positive Despite Giving ...

    Benzinga
  8. Teva Offers Most Attractive Risk-Reward Profile, Citigroup Says

    Benzinga
  9. UPDATE: Goldman Sachs Upgrades Teva Pharmaceutical Industries

    Benzinga
  10. Forest Laboratories' Recovery

    GuruFocus
  11. Should You Buy Actavis?

    GuruFocus
  12. Horizon Pharma Banks On Two-For-One Arthritis Drugs

    IBD
  13. UPDATE: JP Morgan Upgrades Teva Pharmaceuticals

    Benzinga
  14. UPDATE: Morgan Stanley Upgrades Teva Pharmaceutical Industries ...

    Benzinga
  15. Benzinga's Top Upgrades

    Benzinga
  16. US Stock Futures Edge Higher Ahead Of Consumer Sentiment Report

    Benzinga
  17. Pfizer Loses Patent On Celebrex, Plans To Appeal

    IBD
  18. Pfizer Loses Bid to Hold Celebrex Exclusivity to '15

    FoxBusiness
  19. Will Horizon Pharma Spike Again On Quarterly Report?

    IBD
  20. UPDATE: Barclays Upgrades Teva Pharmaceutical Industries Limited ...

    Benzinga
  21. Teva upgraded on drug launch

    IBD
  22. Teva Upgraded On Strong Launch Of Next-Gen Copaxone

    IBD
  23. Weekly 52-Week Highs Highlight: COV, EQT, XLNX, TEVA

    GuruFocus
  24. UPDATE: CRT Capital Initiates Coverage on OncoGenex

    Benzinga
  25. Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With ...

    Benzinga
  26. Insys Recovers From Stock Hit Tied To Fed Probe

    IBD
  27. Generic-Drug Makers Actavis, Mylan To Report Q4 Soon

    IBD
  28. #PreMarket Primer: Friday, February 7: Jobs Friday

    Benzinga
  29. Teva Pharmaceuticals A Giant In Generic Drugs

    IBD
  30. UPDATE: Teva Pharmaceutical Posts Upbeat Q4 Earnings

    Benzinga
  31. Earnings Scheduled For February 6, 2014

    Benzinga
  32. Market Wrap For January 29: Markets Lower on Fed Taper, Emerging ...

    Benzinga
  33. Stocks Hitting 52-Week Highs

    Benzinga
  34. Special Situations Alert: Details Behind Why I Bought PATH

    GuruFocus
  35. Teva, Active Biotech Say Remain Committed to Development of NERVENTRA

    Benzinga
  36. Benzinga's M&A Chatter for Tuesday January 21, 2014

    Benzinga
  37. NuPathe Terminates Agreement With Endo Pharma and Enters Into ...

    Benzinga
  38. US Stock Futures Up; Alcoa Earnings, Jobless Claims Data In Focus

    Benzinga
  39. Drug Mergers Queuing Up

    IBD
  40. Forest Buying Aptalis; Teva Bids For NuPathe Vs. Endo

    IBD
  41. Morning Market Movers

    Benzinga
  42. Benzinga's Top #PreMarket Gainers

    Benzinga
  43. Market Wrap For January 2: Markets Begin 2014 on Negative Note

    Benzinga
  44. Groups of Gurus Trade Ten-Year Low P/B Stocks - CLH, IMO and ...

    GuruFocus
  45. Market Wrap For December 27: Markets Quiet Before Weekend

    Benzinga
  46. Biologic Makers Thwart Generics: Winning Stocks

    YCharts
  47. Morning Market Movers

    Benzinga
  48. Benzinga's Top #PreMarket Gainers

    Benzinga
  49. Stocks To Watch For December 27, 2013

    Benzinga
  50. ANI Pharma Buys 31 Generic Drug Products from Teva for $12.5M ...

    Benzinga
  51. Teva Pharmaceuticals

    IBD
  52. Pfizer Settles Viagra Patent Litigation With Teva

    Benzinga
  53. Why Pfizer’s Expiring Viagra Patent Hurts Lilly Most

    YCharts
  54. Teva Pharmaceutical

    IBD
  55. Teva, Takeda Announce Agreement for Glatiramer Acetate for MSTreatment ...

    Benzinga
  56. Top Five Guru-Held Asian Companies as of the Third Quarter

    GuruFocus
  57. ETF Outlook for the week of December 2, 2013

    Benzinga
  58. Wide Range of ETFs Hitting New Highs (EWN, NLR, EIS, ING, TEVA)

    Benzinga
  59. Teva, Mylan Settle Copaxone Patent Litigation in France, UK, ...

    Benzinga
  60. Teva Says Company Guidance Published in The Maker is Outdated ...

    Benzinga
  61. 2013 3Q 13F Roundup

    Benzinga
  62. Teva Announces Additions to Oncology Biologic Portfolio

    Benzinga
  63. George Soros' Top 10 New Stock Buys

    GuruFocus
  64. Market Wrap For November 11: Relative Quiet as Traders and Investors ...

    Benzinga
  65. Teva Agrees to Pay State of Israel $718M to Settle Tax Assessments

    Benzinga
  66. Eight Interesting Facts about the Twitter IPO (TWTR)

    Benzinga
  67. Bargain Hunting with Phenom Michael Price for 52-Week Lows

    GuruFocus
  68. List: $34B In Pharma Sales Lose Patent in 2014

    YCharts
  69. UPDATE: J.P. Morgan Downgrades Teva Pharmaceutical on Too Much ...

    Benzinga
  70. Benzinga's Top Downgrades

    Benzinga
  71. Teva to Initiate Further Clinical Multiple Sclerosis Trial

    Benzinga
  72. Teva Pharmaceutical's

    IBD
  73. UPDATE: BMO Capital Markets Reiterates on Teva Pharmaceutical ...

    Benzinga
  74. Teva Pharmaceutical

    IBD
  75. Mesoblast Announces FDA Clears IND Filing by Partner Teva to ...

    Benzinga
  76. Teva CEO: I’m Not Quitting; Oh, OK, I Quit!

    YCharts
  77. Stocks Slip Into Narrow Losses; Flextronics, Teva Unravel

    IBD
  78. Teva Hunts for a Successor as CEO Exits

    FoxBusiness
  79. Teva Announces Departure of President and CEO Dr. Jeremy Levin

    Benzinga
  80. UPDATE: Citigroup Initiates Coverage on Teva Pharmaceutical Industries ...

    Benzinga
  81. Generic Drug Industry: Top Five Players

    YCharts
  82. 3 High-Yielding and Low-Priced Large Cap Dividend Growers Close ...

    GuruFocus
  83. Teva Holders Shrug at FDA Approval of Generic-Version of Novartis' ...

    Benzinga
  84. Short Sellers Move On Amgen, Vertex (AMGN, PCYC, VRTX)

    Benzinga
  85. Teva Pharmaceutical Industries

    IBD
  86. One Drug Patent Gone, 5,000 Layoffs Ahead

    YCharts
  87. Teva to Fire 5,000 Workers in Cost-Cutting Move

    FoxBusiness
  88. Pharmaceutical Industry Expected To Collect Billions From Obamacare

    Benzinga
  89. Teva Unveils Generic Zemplar in US

    Benzinga
  90. Teva's Women's Health Unit Says Quartette Now Available in US

    Benzinga
  91. Israel ETFs Bounce Back From Regional Drama

    Benzinga
  92. Top Five Guru-Held Asian Companies as of the Second Quarter

    GuruFocus
  93. Invest in Stocks with a Margin of Safety to Reduce Risk and Enhance ...

    GuruFocus
  94. UPDATE: J.P. Morgan Downgrades Teva, Says No Near-Term Upside ...

    Benzinga
  95. Benzinga's Top Downgrades

    Benzinga
  96. US Stock Futures Flat Ahead Of Economic Data

    Benzinga
  97. Champions Oncology, Teva Announce Partnership for Discovery, ...

    Benzinga
  98. Hard-Core Dividend Growth Manager’s Stock Picks

    YCharts
  99. Eight Calculable Cash Income Stocks at 10-Year Book-Value Lows

    GuruFocus
  100. Top 4 Large-Cap Stocks In The Drug Manufacturers-Other Industry ...

    Benzinga
Trading Center